Compare APGE & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | FMC |
|---|---|---|
| Founded | 2022 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | 2023 | N/A |
| Metric | APGE | FMC |
|---|---|---|
| Price | $70.37 | $16.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 14 |
| Target Price | ★ $103.33 | $23.85 |
| AVG Volume (30 Days) | 873.2K | ★ 3.6M |
| Earning Date | 03-02-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,608,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.20 | $12.17 |
| 52 Week High | $84.56 | $57.00 |
| Indicator | APGE | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 35.02 | 68.30 |
| Support Level | $76.79 | $14.93 |
| Resistance Level | $82.61 | $16.74 |
| Average True Range (ATR) | 4.45 | 0.62 |
| MACD | -0.83 | 0.21 |
| Stochastic Oscillator | 13.02 | 83.39 |
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.